Post-earnings recap
Reported
Thu, Aug 6, 2026
EPS actual
$1.92
EPS est.
$1.48
EPS surprise
+30.17%
1-day move
-18.55%
Collegium Pharmaceutical reported a strong EPS figure, exceeding expectations by over 30%. However, the stock reacted negatively, dropping 18.55%, indicating that investors may have been disappointed by the lack of revenue details or future guidance. The absence of management commentary adds uncertainty to the company's outlook.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.92 | N/A | +30.17% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based solely on numerical results.
Collegium Pharmaceutical, Inc. is a healthcare company focused on developing and commercializing innovative pain management solutions. With a market cap of $1 billion, it plays a significant role in the pharmaceutical industry, particularly in addressing the growing need for effective pain relief options.
Last quarter
In Q1-2026, Collegium reported an EPS of $1.76, significantly exceeding expectations by 43.09%. The stock reacted positively, gaining 7.72% the following day.
EPS beat streak
8Q
EPS beat rate
100%
Avg EPS surprise
+20.70%
Avg 1-day reaction
+1.45%
Overall, there is cautious optimism surrounding Collegium's upcoming earnings report, especially given its strong track record of beating EPS estimates.
Bull case
If Collegium continues its trend of exceeding EPS expectations, it could see a strong positive reaction from investors, potentially leading to further stock price appreciation.
Bear case
Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to a significant decline in stock price, especially given the high implied volatility.
The print will turn on these.
Q1
What will the EPS be for Q2-2026?
Given Collegium's history of beating EPS estimates, the market will closely watch this figure to gauge ongoing profitability.
Q2
How is Collegium's revenue growth tracking compared to previous quarters?
Investors will want to understand the company's sales momentum, as sustained revenue growth is critical for future success.
—
Est. EPS
$1.00
Est. Rev
$14.1B
Impl. Move
±11.9%
Why consensus could be wrong
The Street may underestimate Collegium's ability to sustain high EPS growth due to its innovative product pipeline and market demand.
Supporting evidence
Collegium has consistently beaten EPS estimates, indicating strong operational execution.
The options market is pricing in a significant move, suggesting that investors are expecting more than just a typical performance.
The company's recent product launches have received positive feedback, which may not be fully reflected in current expectations.
Key risk
If Collegium's EPS comes in below $1.50, it could challenge the current bullish sentiment.
Pre-commit to what would confirm each case.
This quarter's performance is pivotal as it will determine whether Collegium can maintain its growth trajectory and investor confidence.
Bull confirmed if
An EPS of $1.80 or higher would confirm the bull case and indicate strong operational performance.
Bear confirmed if
An EPS below $1.50 would confirm the bear case and raise concerns about the company's profitability.
What the market is pricing for the move.
Implied Move
±11.94%
Historical Avg
±6.9%
The options market is pricing in a substantial move, indicating that investors are anticipating significant volatility around the earnings announcement.
Options are pricing ±11.9% while COLL has averaged ±6.9% over the last 8 prints — setup is pricing rich.
ATM IV
0.5%
30d HV
39.8%
Smart-money positioning from the most recent 13F filings.
Institutional
131.08%
of float
Insider
1.15%
of float
Holders
382
institutions
Top Holders· as of Jun 2026
Blackrock Inc.
5,441,202 sh · $119.3M
16.71%
6.0%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Collegium beats expectations, history suggests a potential average one-day move of +4.02%, confirming strong operational performance.
In line / cautious
If results are in line with expectations, the stock may react cautiously, reflecting uncertainty in future growth.
Miss
A miss could lead to a decline, with historical data suggesting an average one-day move down of around -3.34%.
The lines on the call that would change the story.
Jupiter Topco LLC
2,147,072 sh · $47.1M
6.60%
100.0%
Invesco Ltd.
1,882,499 sh · $41.3M
5.78%
18.3%
Fuller & Thaler Asset Management Inc.
1,632,781 sh · $35.8M
5.02%
8.9%
Principal Financial Group, Inc.
1,632,360 sh · $35.8M
5.01%
26.0%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.